US Broker Ratings

Biogen Inc. (BIIB) Investor Outlook: Navigating Growth in the Healthcare Sector with a Potential 7.26% Upside

Biogen Inc. (NASDAQ: BIIB), a formidable player in the healthcare sector, continues to capture attention with its expansive portfolio of therapies and treatments. Based in Cambridge, Massachusetts, Biogen has carved..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Exploring a 19.81% Upside in the Medical Devices Market

GE HealthCare Technologies Inc. (NASDAQ: GEHC) stands as a pivotal player in the medical devices industry, offering a comprehensive range of products and services that spans imaging, advanced visualization solutions,..

Regencell Bioscience Holdings (RGC): Stock Analysis Reveals Strategic Positioning in TCM Market

Regencell Bioscience Holdings Limited (RGC), a Hong Kong-based company specializing in Traditional Chinese Medicine (TCM) for neurocognitive disorders, presents an intriguing yet complex investment case in the healthcare sector. Despite..

argenx SE (ARGX) Stock Analysis: Potential for 14% Upside Amid Robust Growth Prospects

Investors with a keen eye on the biotechnology sector should take note of argenx SE (NASDAQ: ARGX), a Netherlands-based biopharmaceutical company making significant strides in treating autoimmune diseases. With a..

UnitedHealth Group (UNH) Stock Analysis: Exploring a 19.66% Potential Upside Amidst Strong Analyst Support

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare plans industry, continues to capture investor attention with its robust market presence and promising growth prospects. With a substantial market..

Elanco Animal Health (ELAN) Stock Analysis: Strong Buy Ratings and 27.41% Potential Upside

Elanco Animal Health Incorporated (NYSE: ELAN) offers a compelling opportunity for investors seeking exposure in the healthcare sector, specifically within the animal health industry. With a market capitalization of $12.24..

Ascendis Pharma A/S (ASND) Stock Analysis: Unveiling a 16.35% Potential Upside for Investors

Ascendis Pharma A/S (NASDAQ: ASND), a Denmark-based biopharmaceutical innovator, stands out in the biotechnology industry with its promising TransCon-based therapies. With a significant market capitalization of $17.75 billion, Ascendis is..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a 20% Upside in the Biotech Sphere

Roivant Sciences Ltd. (NASDAQ: ROIV), a prominent name in the biotechnology sector, is catching the attention of investors with its potential for a significant upside. With a market capitalization of..

Repligen Corporation (RGEN) Stock Analysis: Uncovering a Potential 11.99% Upside in Bioprocessing

Repligen Corporation (NASDAQ: RGEN) stands out in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $9.46 billion, this Massachusetts-based life sciences company..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: A 25% Upside Potential in Biotech Innovation

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is capturing the attention of investors in the biotechnology sector with its promising focus on metabolic dysfunction-associated steatohepatitis (MASH). The company, which develops novel therapeutics..

Johnson & Johnson (JNJ) Stock Analysis: Navigating a Giant in Healthcare with Solid Revenue Growth

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector, has long been a staple for investors looking for stability and consistent performance. With a market capitalization of $663.28..

Abbott Laboratories (ABT) Stock Analysis: Analyst Consensus Reveals a 10.96% Upside Potential

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector with a focus on medical devices, presents a compelling opportunity for investors seeking stability and growth. With a robust market..

Humana Inc. (HUM) Stock Analysis: Navigating a 4.25% Upside Amid Healthcare Growth

Humana Inc. (NYSE: HUM), a titan in the U.S. healthcare plans sector, presents a compelling proposition for investors seeking stability and growth in the healthcare industry. With a market capitalization..

Moderna, Inc. (MRNA) Stock Analysis: Is the Biotech Giant’s Market Cap Justified Amid a 19.96% Potential Downside?

Moderna, Inc. (MRNA), a leading figure in the biotechnology sector, has captivated investor attention with its robust portfolio of messenger RNA medicines. Despite its current standing with a market capitalization..

Penumbra, Inc. (PEN): Growth Potential Amidst Analyst Consensus and Market Dynamics

For investors eyeing opportunities in the medical device sector, Penumbra, Inc. (PEN) presents a compelling case with its innovative product lineup and robust market presence. With a market capitalization of..

Amgen Inc. (AMGN) Stock Analysis: Evaluating the Dividend Potential and Analyst Ratings in a Competitive Market

Amgen Inc. (NASDAQ: AMGN), a leading player in the healthcare sector, continues to capture investor attention with its robust portfolio of human therapeutics and a significant market capitalization of $236.38..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: A Strong Buy with 13.23% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI) has established itself as a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a current market cap..

ResMed Inc. (RMD) Stock Analysis: Navigating a 7.78% Upside Potential in the Healthcare Sector

ResMed Inc. (RMD), a prominent player in the healthcare sector, has garnered investor attention with its robust market presence in the medical instruments and supplies industry. With a market capitalization..

Charles River Laboratories Inte (CRL): Analyst Consensus and Growth Potential Amidst Market Volatility

Charles River Laboratories International, Inc. (CRL) stands as a significant player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $13.9 billion, this..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds